PJSC Pharmaceutical Factory “Viola” has successfully passed the next stage of certification and received new certificates confirming that its medicine production conditions comply with the requirements of Good Manufacturing Practice (GMP).
Following a comprehensive inspection carried out by the State Service of Ukraine on Medicines and Drugs Control, the company received official confirmation of the high quality of its production processes in accordance with the Guideline of the State Service of Ukraine on Medicines and Drugs Control 42-4.0:2020 “Medicines. Good Manufacturing Practice.” These standards are fully harmonized with PIC/S requirements, EU directives, and WHO recommendations.
The inspection confirmed the stability and safety of production at all key technological sites.
The following production facilities have been successfully certified:
- Site for the production of solid medicines from plant raw materials — Certificate No. 047/2026/GMP (valid until 27.02.2028). Specialization: mixtures, teas, and packaged medicinal plant raw materials.
- Solid medicines production site — Certificate No. 046/2026/GMP (valid until 27.02.2028). Specialization: hard capsules.
- Site for the production of liquid and solid medicines — Certificate No. 048/2026/GMP (valid until 27.02.2028). Specialization: liquids for external and internal use, powders.
- Soft medicines production site — Certificate No. 030/2025/GMP (valid until 22.11.2026). Specialization: ointments, gels, liniments, pastes, and liquids for external and internal use.
From now on, 100% of the company’s production workshops are GMP certified, which is a recognized global standard in the pharmaceutical industry.
Achieving full certification according to GMP standards opens up new opportunities for the systematic development and scaling of PJSC Pharmaceutical Factory “Viola”:
- Expansion of presence in international markets: certificates harmonized with EU directives and PIC/S standards remove regulatory barriers and allow the company to significantly intensify export activities, focusing on the markets of Europe, Asia, and the Middle East.
- Deepening of research and production potential: the company plans to continue investing in the modernization of its laboratory and research complex and in expanding its line of medicines.
- Development of contract manufacturing: with fully certified high-tech workshops, the factory plans to attract new national and foreign partners for contract manufacturing services.
Receipt of these documents is further evidence that PJSC Pharmaceutical Factory “Viola” strictly adheres to international standards, providing Ukrainian and foreign consumers with effective, high-quality, and safe medicines.
Successful GMP certification is a long-term platform for the company’s innovative growth and confirms its status as one of the leaders of the Ukrainian pharmaceutical industry.
We express our sincere gratitude to the entire team of the enterprise for their high professionalism and significant contribution to the common result!
